Type 2 Diabetes Research Study
Type 2 diabetes is a progressive condition that is currently affecting about 30 million Americans. In most cases, type 2 diabetes leads to, or is accompanied by, high cholesterol and heart diseases. Despite available treatments, there is a significant need for options that achieve acceptable blood sugar control and lowers cholesterol levels.
Accellacare is enrolling volunteers to evaluate an investigational medication for type 2 diabetes. Learn more today!
Submit to learn more:
Please note: You may or may not benefit medically from taking part and you are able to opt out at anytime and do not have to give us a reason for doing so. Your primary care physician will be informed about your participation and all medical assessments that will be carried out as part of the study. If during screening any abnormal results are found your primary care physician will also be informed.